60 years) patients (p = 0.039). Toxicity differences in all other scales were not significant. Between older (> 60 years) and midaged patients (50-60 years) no significant differences in toxicity were found. This was also true for the comparison between young (< 50 years) versus midaged patient groups (50-60 years). Conclusion The treatment concept of BCT for breast cancer is generally well tolerated. The toxicity-measurement with the new topographic module is feasible. Not modified standard treatment for BC should be performed in elderly women."/>
Skip to main content

Table 3 Toxicity documentation: measurement points t1-t8 (Percentages)

From: Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification

Scale Mesurement-point Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
Axilla: Pain t1 51.61% 39.78% 8.60% 0.00% 0.00%
  t2 52.17% 40.22% 7.61% 0.00% 0.00%
  t3 53.26% 41.30% 5.43% 0.00% 0.00%
  t4 58.06% 38.71% 3.23% 0.00% 0.00%
  t5 56.52% 42.39% 1.09% 0.00% 0.00%
  t6 63.74% 35.16% 1.10% 0.00% 0.00%
  t8 85.71% 14.29% 0.00% 0.00% 0.00%
Axilla: Hair loss t1 100.00% 0.00% 0.00% 0.00% xxx
  t2 98.91% 1.09% 0.00% 0.00% xxx
  t3 100.00% 0.00% 0.00% 0.00% xxx
  t4 97.85% 1.08% 1.08% 0.00% xxx
  t5 98.91% 1.09% 0.00% 0.00% xxx
  t6 100.00% 0.00% 0.00% 0.00% xxx
  t8 100.00% 0.00% 0.00% 0.00% xxx
Axilla: sweat gland function t1 100.00% 0.00% 0.00% 0.00% xxx
  t2 100.00% 0.00% 0.00% 0.00% xxx
  t3 100.00% 0.00% 0.00% 0.00% xxx
  t4 100.00% 0.00% 0.00% 0.00% xxx
  t5 100.00% 0.00% 0.00% 0.00% xxx
  t6 100.00% 0.00% 0.00% 0.00% xxx
  t8 100.00% 0.00% 0.00% 0.00% xxx
Arm: Lymphedema t1 62.37% 37.63% 0.00% 0.00% 0.00%
  t2 60.87% 38.04% 1.09% 0.00% 0.00%
  t3 63.04% 36.96% 0.00% 0.00% 0.00%
  t4 61.29% 38.71% 0.00% 0.00% 0.00%
  t5 61.96% 38.04% 0.00% 0.00% 0.00%
  t6 62.64% 37.36% 0.00% 0.00% 0.00%
  t8 60.00% 37.14% 2.86% 0.00% 0.00%
Arm: Function t1 39.78% 53.76% 6.45% 0.00% 0.00%
  t2 42.39% 54.35% 3.26% 0.00% 0.00%
  t3 46.15% 52.75% 1.10% 0.00% 0.00%
  t4 48.39% 51.61% 0.00% 0.00% 0.00%
  t5 53.26% 46.74% 0.00% 0.00% 0.00%
  t6 59.34% 39.56% 1.10% 0.00% 0.00%
  t8 71.43% 28.57% 0.00% 0.00% 0.00%